Physician profile
Miranda Goransson
NPI 1871156034
$2,554.95
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $1,185 · 2021: $716 · 2022: $654.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Southern Edge Orthopaedics, INC. | $895.33 | 2020 | |
| Biotissue Holdings INC. | $462.54 | 2021-2022 | |
| Stryker Corporation | $249.39 | 2022 | |
| Horizon Therapeutics Plc | $229.56 | 2021 | |
| Amniox Medical, INC. | $169.61 | 2020 | |
| Heron Therapeutics, INC. | $124.98 | 2021 | |
| Nevro Corp. | $121.93 | 2022 | |
| Kci USA, INC. | $100.00 | 2022 | |
| Allergan, INC. | $97.60 | 2020 | |
| Cardiovascular Systems INC. | $58.21 | 2021 | |
| Philips North America LLC | $23.60 | 2021 | |
| Csl Behring | $22.20 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Miranda Goransson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.